GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Supriya Lifescience Ltd (BOM:543434) » Definitions » Price-to-Owner-Earnings

Supriya Lifescience (BOM:543434) Price-to-Owner-Earnings : 40.08 (As of Jun. 24, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Supriya Lifescience Price-to-Owner-Earnings?

As of today (2024-06-24), Supriya Lifescience's share price is ₹397.20. Supriya Lifescience's Owner Earnings per Share (TTM) ended in Mar. 2024 was ₹9.91. It's Price-to-Owner-Earnings for today is 40.08.


The historical rank and industry rank for Supriya Lifescience's Price-to-Owner-Earnings or its related term are showing as below:

BOM:543434' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 36.48   Med: 41.43   Max: 51.82
Current: 40.08

During the past 6 years, the highest Price-to-Owner-Earnings of Supriya Lifescience was 51.82. The lowest was 36.48. And the median was 41.43.


BOM:543434's Price-to-Owner-Earnings is ranked worse than
56.02% of 166 companies
in the Biotechnology industry
Industry Median: 33.19 vs BOM:543434: 40.08

As of today (2024-06-24), Supriya Lifescience's share price is ₹397.20. Supriya Lifescience's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹14.80. Therefore, Supriya Lifescience's PE Ratio for today is 26.84.

As of today (2024-06-24), Supriya Lifescience's share price is ₹397.20. Supriya Lifescience's EPS without NRI for the trailing twelve months (TTM) ended in was ₹14.80. Therefore, Supriya Lifescience's PE Ratio without NRI for today is 26.84.

During the past 6 years, Supriya Lifescience's highest PE Ratio without NRI was 27.74. The lowest was 8.26. And the median was 18.99.


Supriya Lifescience Price-to-Owner-Earnings Historical Data

The historical data trend for Supriya Lifescience's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Supriya Lifescience Price-to-Owner-Earnings Chart

Supriya Lifescience Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Price-to-Owner-Earnings
Get a 7-Day Free Trial - - - 38.41 33.48

Supriya Lifescience Quarterly Data
Mar19 Mar20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.41 - - - 33.48

Competitive Comparison of Supriya Lifescience's Price-to-Owner-Earnings

For the Biotechnology subindustry, Supriya Lifescience's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Supriya Lifescience's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Supriya Lifescience's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Supriya Lifescience's Price-to-Owner-Earnings falls into.



Supriya Lifescience Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Supriya Lifescience's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=397.20/9.91
=40.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Supriya Lifescience  (BOM:543434) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Supriya Lifescience Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Supriya Lifescience's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Supriya Lifescience (BOM:543434) Business Description

Traded in Other Exchanges
Address
Sonawala Road, 207/208, Udyog Bhavan, Goregaon East, Mumbai, MH, IND, 400063
Supriya Lifescience Ltd is a manufacturer of Active pharmaceutical Ingredients. It is focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and anti-allergic.

Supriya Lifescience (BOM:543434) Headlines

No Headlines